Abstract
The Authors, considering 141 cases of patient women under 40, suffering from breast cancer, analyse the prognostic factors in relation to the different therapeutical approach, histologic type, dimensions of T, and presence or absence of metastases at the axillary lymph nodes. They, moreover, appraise the actuarial global survival with no disease (NED) of this group of patients as compared with the survival of women in more advanced age.
MeSH terms
-
Adult
-
Age Factors
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Breast Neoplasms / drug therapy
-
Breast Neoplasms / mortality
-
Breast Neoplasms / pathology
-
Breast Neoplasms / radiotherapy
-
Breast Neoplasms / surgery*
-
Combined Modality Therapy
-
Cyclophosphamide / therapeutic use
-
Female
-
Fluorouracil / therapeutic use
-
Humans
-
Lymphatic Metastasis
-
Methotrexate / therapeutic use
-
Prognosis
-
Retrospective Studies
Substances
-
Cyclophosphamide
-
Fluorouracil
-
Methotrexate